Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (11-20 of 350) with videos related to

Pageof 35
Sort By:
Leukemia|November 25, 2010
Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemiaD Bixby, M Talpaz
Leukemia & Lymphoma|February 1, 1997
Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell deathZ Estrov, M Talpaz
Cytokines and Molecular Therapy|March 1, 1996
Role of interleukin-1 beta converting enzyme (ICE) in leukemiaZ Estrov, M Talpaz
Experimental Hematology|September 1, 1984
Low natural killer cell activity in the bone marrow of healthy donors with normal killer cell activity in the peripheral bloodM Talpaz, G Spitzer
Seminars in Oncology|December 12, 2001
Imatinib mesylate: clinical results in Philadelphia chromosome-positive leukemiasH M Kantarjian, M Talpaz
Cancer Treatment Reports|March 1, 1982
Vindesine-associated angina and ECG changesR S Yancey, M Talpaz
Journal of Clinical & Laboratory Immunology|December 1, 1983
Characterization of human effector and suppressor T cells by their activity in mixed lymphocyte reaction and by monoclonal antibody phenotypingM Talpaz, G M Mavligit
Blood|October 9, 1998
Questions raised by the Benelux CML Study Group: results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha2b for chronic myeloid leukemiaH M Kantarjian, M Talpaz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Definition of the accelerated phase of chronic myelogenous leukemiaH M Kantarjian, M Talpaz
Leukemia & Lymphoma|January 1, 1993
Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer CenterH M Kantarjian, M Talpaz
Pageof 35

Showing results (11-20 of 350) with videos related to

Sort By:
Pageof 35
Leukemia|November 25, 2010
Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemiaD Bixby, M Talpaz
Leukemia & Lymphoma|February 1, 1997
Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell deathZ Estrov, M Talpaz
Cytokines and Molecular Therapy|March 1, 1996
Role of interleukin-1 beta converting enzyme (ICE) in leukemiaZ Estrov, M Talpaz
Experimental Hematology|September 1, 1984
Low natural killer cell activity in the bone marrow of healthy donors with normal killer cell activity in the peripheral bloodM Talpaz, G Spitzer
Seminars in Oncology|December 12, 2001
Imatinib mesylate: clinical results in Philadelphia chromosome-positive leukemiasH M Kantarjian, M Talpaz
Cancer Treatment Reports|March 1, 1982
Vindesine-associated angina and ECG changesR S Yancey, M Talpaz
Journal of Clinical & Laboratory Immunology|December 1, 1983
Characterization of human effector and suppressor T cells by their activity in mixed lymphocyte reaction and by monoclonal antibody phenotypingM Talpaz, G M Mavligit
Blood|October 9, 1998
Questions raised by the Benelux CML Study Group: results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha2b for chronic myeloid leukemiaH M Kantarjian, M Talpaz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Definition of the accelerated phase of chronic myelogenous leukemiaH M Kantarjian, M Talpaz
Leukemia & Lymphoma|January 1, 1993
Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer CenterH M Kantarjian, M Talpaz
Pageof 35